CC notes today,amazing.
To access the replay, dial +1 (844) 512-2921 (United States) or +1 (412) 317-6671 (International) and enter replay pin number: 9762238.
Key facts:
1. They are getting 3 cancer samples a week now, for building tumors outside body, that will go way up.
2. To best of their knowledge AIPT is the only company working on growing cancer tumors that are "clones" of real ones in a patient for testing various treatments on them. Amazing IMHO.
3. They plan by 4Q to actually be able to grow a tumor outside the body that thinks it is still inside.
4. They said Helomics spent $180 million!!!! creating its cancer database (and AIPT got it for about $7.5 million in mostly stock)
5. Headcount is 18 at Helomics today.
6. Financially the most amazing thing is they project by selling data and services to drug companies that Helomics will be cashflow positive by 3Q 2018!! To me shockingly good news. Their sales projections for Streamway in Dec proving out in 1Q, so if true just amazing good news.
7. They sounded sharp, well done presentation.
8.They agreed the precision segment has potential to be over $500 million in rev for them. Remember they are only about $15 million mkt cap today. At 3x sales that would be $1.5 billion mkt cap, That would be 100 bagger, BUT they will have to dilute IMHO to do it. If 3 times dilute, that would still be a 30+ bagger.
Glad am in the stock.
